Home
>
National Drug Code (NDC)
>
Trandate
Trandate - 65483-392-10 - (labetalol hydrochloride)
Drug Information of Trandate
| Product NDC: | 65483-392 |
| Proprietary Name: | Trandate |
| Non Proprietary Name: | labetalol hydrochloride |
| Active Ingredient(s): | 200 mg/1 & nbsp; labetalol hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Trandate
| Product NDC: | 65483-392 |
| Labeler Name: | Prometheus Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018716 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19840531 |
Package Information of Trandate
| Package NDC: | 65483-392-10 |
| Package Description: | 100 TABLET in 1 BOTTLE (65483-392-10) |
NDC Information of Trandate
| NDC Code | 65483-392-10 |
| Proprietary Name | Trandate |
| Package Description | 100 TABLET in 1 BOTTLE (65483-392-10) |
| Product NDC | 65483-392 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | labetalol hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19840531 |
| Marketing Category Name | NDA |
| Labeler Name | Prometheus Laboratories Inc. |
| Substance Name | LABETALOL HYDROCHLORIDE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
